DDDD

4D PHARMA PLC ORD 0.25P

TitleTime
Directorate ChangeThu 21/05/20 | 07:00
Holding(s) in CompanyTue 19/05/20 | 18:20
Holding(s) in CompanyTue 12/05/20 | 18:06
Completion of immuno-oncology study safety phaseMon 11/05/20 | 07:00
Holding(s) in CompanyFri 24/04/20 | 11:30
Phase II study in COVID-19Mon 20/04/20 | 07:00
Appointment of Non-Executive ChairpersonFri 17/04/20 | 07:00
Interim analysis of Blautix phase II study dataFri 17/04/20 | 07:00
Second Price Monitoring ExtnMon 30/03/20 | 12:08
Price Monitoring ExtensionMon 30/03/20 | 12:03
Price Monitoring ExtensionThu 19/03/20 | 16:36
Holding(s) in CompanyThu 19/03/20 | 09:47
Second Price Monitoring ExtnWed 18/03/20 | 16:44
Price Monitoring ExtensionWed 18/03/20 | 16:39
Director/PDMR ShareholdingWed 18/03/20 | 07:49
Holding(s) in CompanyWed 11/03/20 | 09:49
Holding(s) in CompanyWed 11/03/20 | 07:00
Result of MeetingMon 09/03/20 | 11:07
Holding(s) in CompanyFri 21/02/20 | 14:25
Posting of CircularWed 19/02/20 | 14:06
Result of PlacingTue 18/02/20 | 18:28
Launch of PlacingTue 18/02/20 | 07:00
Holding(s) in CompanyFri 07/02/20 | 15:18
Holding(s) in CompanyWed 04/12/19 | 11:22
Holding(s) in CompanyFri 29/11/19 | 11:19
Holding(s) in CompanyFri 08/11/19 | 11:27
Clinical Observations from MRx0518Wed 06/11/19 | 07:00
Holding(s) in CompanyTue 05/11/19 | 17:36
Holding(s) in CompanyMon 04/11/19 | 12:22
Holding(s) in CompanyMon 04/11/19 | 12:04
Holding(s) in CompanyThu 17/10/19 | 11:17
Holding(s) in CompanyTue 15/10/19 | 14:51
Collaboration with MSDTue 08/10/19 | 07:00
Interim ResultsMon 30/09/19 | 07:00
Holding(s) in CompanyFri 27/09/19 | 12:23
Holding(s) in CompanyThu 26/09/19 | 11:40
Holding(s) in CompanyFri 20/09/19 | 13:28
Holding(s) in CompanyFri 20/09/19 | 13:19
Holding(s) in CompanyFri 20/09/19 | 11:20
Appointment of NEDTue 27/08/19 | 07:00
Holding(s) in CompanyMon 08/07/19 | 15:51
Change of AdviserMon 01/07/19 | 07:00
Result of AGMThu 20/06/19 | 10:38
Director/PDMR ShareholdingThu 30/05/19 | 07:00
Annual Report and Notice of AGMTue 28/05/19 | 14:50
Director/PDMR ShareholdingThu 23/05/19 | 07:00
Director/PDMR ShareholdingWed 22/05/19 | 07:00
Final ResultsTue 21/05/19 | 07:00
Director/PDMR ShareholdingThu 14/03/19 | 07:00
Director/PDMR ShareholdingWed 13/03/19 | 09:08
Appointment of independent Non-Executive DirectorsTue 08/01/19 | 07:00
Director/PDMR ShareholdingFri 21/12/18 | 07:00
Director/PDMR ShareholdingWed 19/12/18 | 07:00
PDMR DealingsThu 13/12/18 | 07:00
Second Price Monitoring ExtnWed 12/12/18 | 16:40
Price Monitoring ExtensionWed 12/12/18 | 16:35
Trading StatementWed 12/12/18 | 07:00
Clinical Update - Blautix Phase II studyThu 08/11/18 | 07:00
Interim resultsFri 28/09/18 | 07:00
Clinical update and publication of studiesMon 24/09/18 | 07:00
Second Price Monitoring ExtnMon 25/06/18 | 16:40
Price Monitoring ExtensionMon 25/06/18 | 16:35
Holding(s) in CompanyTue 12/06/18 | 16:51
Clinical Collaboration AgreementThu 07/06/18 | 07:00
4D Presents Phase Ib Clinical Data on BlautixMon 04/06/18 | 07:00
Result of AGMMon 21/05/18 | 12:08
MRx0518 - Monotherapy trial approvedMon 21/05/18 | 07:00
Clinical Update - Blautix INDTue 08/05/18 | 07:00
Annual Report and Notice of AGMThu 26/04/18 | 07:00
Final ResultsMon 23/04/18 | 07:00
Oncology candidate updateWed 21/03/18 | 07:00
Appointment of Joint BrokerTue 20/02/18 | 07:00
Interim resultsThu 28/09/17 | 07:00
Holding(s) in CompanyTue 05/09/17 | 12:54
Issue of EquityThu 24/08/17 | 07:00